EE04219B1 - Säilituskindel toimeainekontsentraat formoterooliga - Google Patents

Säilituskindel toimeainekontsentraat formoterooliga

Info

Publication number
EE04219B1
EE04219B1 EEP200100224A EEP200100224A EE04219B1 EE 04219 B1 EE04219 B1 EE 04219B1 EE P200100224 A EEP200100224 A EE P200100224A EE P200100224 A EEP200100224 A EE P200100224A EE 04219 B1 EE04219 B1 EE 04219B1
Authority
EE
Estonia
Prior art keywords
formoterol
storage
active ingredient
stable active
ingredient concentrate
Prior art date
Application number
EEP200100224A
Other languages
English (en)
Estonian (et)
Inventor
Hochrainer Dieter
Zierenberg Bernd
Original Assignee
Boehringer Ingelheim Pharma Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19847969A external-priority patent/DE19847969A1/de
Application filed by Boehringer Ingelheim Pharma Kg filed Critical Boehringer Ingelheim Pharma Kg
Publication of EE200100224A publication Critical patent/EE200100224A/xx
Publication of EE04219B1 publication Critical patent/EE04219B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EEP200100224A 1998-10-17 1999-10-09 Säilituskindel toimeainekontsentraat formoterooliga EE04219B1 (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19847969A DE19847969A1 (de) 1998-10-17 1998-10-17 Lagerfähig flüssige Formulierung mit Formoterol
US11238098P 1998-12-14 1998-12-14
PCT/EP1999/007581 WO2000023065A2 (de) 1998-10-17 1999-10-09 Lagerfähiges wirkstoffkonzentrat mit formoterol

Publications (2)

Publication Number Publication Date
EE200100224A EE200100224A (et) 2002-06-17
EE04219B1 true EE04219B1 (et) 2004-02-16

Family

ID=26049594

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200100224A EE04219B1 (et) 1998-10-17 1999-10-09 Säilituskindel toimeainekontsentraat formoterooliga

Country Status (26)

Country Link
EP (1) EP1121112B1 (xx)
JP (2) JP3636430B2 (xx)
KR (1) KR100655100B1 (xx)
CN (1) CN1187044C (xx)
BG (1) BG65350B1 (xx)
BR (1) BR9914507A (xx)
CA (1) CA2343123C (xx)
CZ (1) CZ20011362A3 (xx)
DE (1) DE59901669D1 (xx)
DK (1) DK1121112T3 (xx)
EA (1) EA003960B1 (xx)
EE (1) EE04219B1 (xx)
ES (1) ES2178479T3 (xx)
HK (1) HK1041448B (xx)
HR (1) HRP20010255A2 (xx)
HU (1) HUP0103925A3 (xx)
ID (1) ID29605A (xx)
IL (2) IL142494A0 (xx)
NO (1) NO20011663L (xx)
NZ (1) NZ511225A (xx)
PL (1) PL348434A1 (xx)
PT (1) PT1121112E (xx)
SI (1) SI1121112T1 (xx)
SK (1) SK285382B6 (xx)
TR (1) TR200101096T2 (xx)
WO (1) WO2000023065A2 (xx)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
IT1317846B1 (it) 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
CZ303833B6 (cs) * 2000-05-22 2013-05-22 Chiesi Farmaceutici S.P.A. Aerosolový prostredek
US20030055026A1 (en) * 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
US6667344B2 (en) * 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
ITRM20040268A1 (it) * 2004-05-31 2004-08-31 Italchimici S P A Formulazione farmaceutica di una soluzione stabile di formoterolo per via inalatoria e suo precedimento di preparazione.
ITRM20050022A1 (it) 2005-01-19 2006-07-20 Italchimici S P A Formulazione farmaceutica di una soluzione stabile di glicole propilenico contenente formoterolo per via inalatoria e suo procedimento di preparazione.
WO2007059620A1 (en) * 2005-11-23 2007-05-31 Feanny Stephen J Method for administering formoterol using a nebulizer
DE102006023756A1 (de) * 2006-05-20 2007-11-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ethanolhaltige Aerosolformulierung für die Inhalation
CA2653744C (en) * 2006-05-26 2018-01-16 Dey, L.P. Nebulizable compositions of quaternary ammonium muscarinic receptor antagonists
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
EP2414560B1 (de) 2009-03-31 2013-10-23 Boehringer Ingelheim International GmbH Verfahren zur beschichtung einer oberfläche eines bauteils
JP5763053B2 (ja) 2009-05-18 2015-08-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング アダプタ、吸入器具及びアトマイザ
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
JP5658268B2 (ja) 2009-11-25 2015-01-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
WO2011064164A1 (en) 2009-11-25 2011-06-03 Boehringer Ingelheim International Gmbh Nebulizer
WO2011160932A1 (en) 2010-06-24 2011-12-29 Boehringer Ingelheim International Gmbh Nebulizer
WO2012130757A1 (de) 2011-04-01 2012-10-04 Boehringer Ingelheim International Gmbh Medizinisches gerät mit behälter
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
JP6643231B2 (ja) 2013-08-09 2020-02-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
EP2835146B1 (en) 2013-08-09 2020-09-30 Boehringer Ingelheim International GmbH Nebulizer
PL3139984T3 (pl) 2014-05-07 2021-11-08 Boehringer Ingelheim International Gmbh Nebulizator
LT3928818T (lt) 2014-05-07 2023-03-27 Boehringer Ingelheim International Gmbh Purkštuvas ir talpa
JP6580070B2 (ja) 2014-05-07 2019-09-25 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 容器、ネブライザ、及び使用
CN107362140A (zh) * 2016-05-11 2017-11-21 广东东阳光药业有限公司 喷雾剂以及喷雾组件
CN111936124A (zh) * 2018-07-26 2020-11-13 四川海思科制药有限公司 一种含格隆铵盐及茚达特罗盐的气雾剂药物组合物及其制备方法与应用
CN110755414A (zh) * 2019-11-12 2020-02-07 南京华盖制药有限公司 一种酒石酸阿福特罗气雾剂及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69218455T2 (de) * 1991-12-18 1997-10-23 Minnesota Mining And Mfg. Co., Saint Paul, Minn. Aerosolzusammensetzungen für arzneimittelsuspensionen
GB9612297D0 (en) * 1996-06-11 1996-08-14 Minnesota Mining & Mfg Medicinal aerosol formulations
GB9616237D0 (en) * 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations

Also Published As

Publication number Publication date
ID29605A (id) 2001-09-06
JP2002527473A (ja) 2002-08-27
HRP20010255A2 (en) 2002-04-30
PL348434A1 (en) 2002-05-20
ES2178479T3 (es) 2002-12-16
HK1041448B (zh) 2005-05-13
CA2343123C (en) 2008-03-25
CZ20011362A3 (cs) 2001-09-12
SK285382B6 (sk) 2006-12-07
SI1121112T1 (en) 2002-10-31
KR100655100B1 (ko) 2006-12-08
BR9914507A (pt) 2001-06-26
NO20011663D0 (no) 2001-04-03
PT1121112E (pt) 2002-11-29
HUP0103925A3 (en) 2003-05-28
EP1121112B1 (de) 2002-06-05
HK1041448A1 (en) 2002-07-12
DE59901669D1 (de) 2002-07-11
IL142494A (en) 2006-04-10
NO20011663L (no) 2001-04-03
KR20010075637A (ko) 2001-08-09
BG105391A (en) 2001-11-30
CA2343123A1 (en) 2000-04-27
CN1333682A (zh) 2002-01-30
EE200100224A (et) 2002-06-17
JP3636430B2 (ja) 2005-04-06
DK1121112T3 (da) 2002-09-16
SK4942001A3 (en) 2001-09-11
JP2005047933A (ja) 2005-02-24
HUP0103925A2 (hu) 2002-05-29
WO2000023065A2 (de) 2000-04-27
EP1121112A2 (de) 2001-08-08
BG65350B1 (bg) 2008-03-31
TR200101096T2 (tr) 2001-12-21
IL142494A0 (en) 2002-03-10
EA200100439A1 (ru) 2001-10-22
NZ511225A (en) 2003-08-29
WO2000023065A8 (de) 2001-02-22
WO2000023065A3 (de) 2000-08-03
CN1187044C (zh) 2005-02-02
EA003960B1 (ru) 2003-10-30

Similar Documents

Publication Publication Date Title
EE200100224A (et) Säilituskindel toimeainekontsentraat formoterooliga
ATE218331T1 (de) Lagerfähiges wirkstoffkonzentrat mit formoterol
DE69918074D1 (de) Makrolid-formulierung mit verzögerter wirkstoffabgabe
DK1062217T3 (da) Herbicidt aktive 3-hydroxy-4-aryl-5-oxopyrazolinderivater
DE69821940D1 (de) Landwirtschaftlich aktive inhaltsstoffe enthaltende mikropartikel
ATE223646T1 (de) Agrochemische formulierungen
DE69942921D1 (de) Osmotische Dosierungsform mit verlängerter Wirkstoffabgabe
NO20003721D0 (no) Farmasøytisk aktivt morfolinol
DE59906523D1 (de) Synergistische insektizide mischungen
NO20012915L (no) Ny farmasöytisk formulering
DE60005091D1 (de) Viruzide und sporizide Zusammensetzung
BR9709422A (pt) Formulações concentradas líquidas compreendendo um ingrediente microbicidaments ativo
FR2780857B1 (fr) Agent pesticide
DE50002452D1 (de) Synergistische insektizide mischungen
ATE249739T1 (de) Agrochemische formulierungen
DE60031633D1 (de) Wirkstofffreisetzendes elastisches band
LV12624A (lv) Thienylazolylalcoxyethanamines their preparation and their application as medicaments
BR9901100B1 (pt) composiÇço fungicida lÍquida e concentrada.
NO20020793D0 (no) Virkestoffkombinasjon med clonidin
DE69919490D1 (de) Puder mit fettlöslichem wirkstoff
ATE298576T1 (de) Arzneizubereitungen
PT1161148E (pt) Composicoes insecticidas sinergeticas
DE60000808D1 (de) Fliessbare Pestizide Öl-in-Wasser Formulierungen
DE69905278D1 (de) Insectizide mittel
ATE237309T1 (de) Arzneizubereitungen

Legal Events

Date Code Title Description
HC1A Change of owner name
KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

MM4A Lapsed by not paying the annual fees

Effective date: 20081009